Nutex Health (NASDAQ:NUTX) Stock Price Up 13.1% – Here’s What Happened

by · The Markets Daily

Nutex Health Inc. (NASDAQ:NUTX – Get Free Report) shot up 13.1% on Wednesday. The stock traded as high as $203.08 and last traded at $203.0450. Approximately 92,673 shares changed hands during trading, a decline of 44% from the average daily volume of 166,780 shares. The stock had previously closed at $179.58.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on NUTX shares. Weiss Ratings raised Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Tuesday, October 6th. B. Riley Financial reissued a “buy” rating on shares of Nutex Health in a research report on Friday, September 4th. LADENBURG THALM/SH SH assumed coverage on shares of Nutex Health in a research report on Monday, October 26th. They issued a “buy” rating and a $336.00 target price on the stock. Lake Street Capital reiterated a “buy” rating and issued a $310.00 price target (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Finally, Zacks Research cut shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $323.67.

Get Our Latest Analysis on Nutex Health

Nutex Health Stock Down 6.8%

The stock has a 50 day simple moving average of $203.37 and a 200-day simple moving average of $151.24. The firm has a market cap of $1.24 billion, a PE ratio of 7.09 and a beta of 0.66. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96.

Nutex Health (NASDAQ:NUTX – Get Free Report) last released its earnings results on Thursday, November 5th. The company reported $5.71 EPS for the quarter, topping analysts’ consensus estimates of $5.54 by $0.17. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. The firm had revenue of $217.61 million for the quarter, compared to analysts’ expectations of $214.82 million. Sell-side analysts predict that Nutex Health Inc. will post 26.65 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Scott Saunders sold 203 shares of the stock in a transaction dated Friday, September 18th. The shares were sold at an average price of $214.25, for a total transaction of $43,492.75. Following the sale, the director directly owned 400 shares of the company’s stock, valued at approximately $85,700. This represents a 33.67% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 44.68% of the company’s stock.

Institutional Investors Weigh In On Nutex Health

A number of institutional investors have recently made changes to their positions in NUTX. Fulcrum Asset Management LLP raised its position in Nutex Health by 168.8% in the 3rd quarter. Fulcrum Asset Management LLP now owns 1,930 shares of the company’s stock worth $405,000 after buying an additional 1,212 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in shares of Nutex Health by 10.1% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,639 shares of the company’s stock valued at $773,000 after acquiring an additional 335 shares during the last quarter. Bridge City Capital LLC bought a new stake in shares of Nutex Health in the third quarter worth approximately $3,918,000. VIRGINIA RETIREMENT SYSTEMS ET Al raised its holdings in shares of Nutex Health by 3.8% during the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 5,500 shares of the company’s stock valued at $1,164,000 after purchasing an additional 200 shares during the last quarter. Finally, BOKF NA purchased a new position in shares of Nutex Health during the third quarter valued at approximately $501,000. Hedge funds and other institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

(Get Free Report)

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.

Featured Articles